• Alisol A Regulates Cholesterol and Autophagy in Vascular Cog

  2026-05-29

  This study demonstrates that Alisol A, a triterpenoid from traditional Chinese medicine, ameliorates vascular cognitive impairment (VCI) by restoring cholesterol homeostasis and promoting mitophagy via the AMPK/NAMPT/SIRT1 axis. The findings highlight a mechanistic link between lipid metabolism, autophagy, and neuroprotection, offering new therapeutic insights for atherosclerosis-related cognitive decline.

• Annexin V-PE Apoptosis Detection Kit: Innovations for Immuno

  2026-05-28

  Unlock advanced apoptosis detection in live cells with the Annexin V-PE Apoptosis Detection Kit. This comprehensive guide explores assay optimization, practical immunology applications, and scientific insights from recent translational research.

• In Vitro Susceptibility of Canine Staphylococci to Mupirocin

  2026-05-28

  This study systematically assessed the susceptibility of both meticillin-resistant and meticillin-susceptible staphylococci from dogs to mupirocin and novobiocin. The findings clarify the efficacy of these antimicrobials against canine staphylococci, emphasizing their potential roles in addressing emerging resistance in veterinary infections.

• Ceftazidime in Gram-Negative Infection Research: Advanced Wo

  2026-05-27

  Ceftazidime, a third-generation cephalosporin from APExBIO, stands out for its robust activity against Gram-negative pathogens such as Pseudomonas aeruginosa. This article delivers actionable protocols, troubleshooting guidance, and research-driven insights for maximizing ceftazidime’s utility in experimental models of bacterial pneumonia, bronchitis, and multidrug resistance.

• Microglial Activation and Seizure Susceptibility in Acute Al

  2026-05-27

  This study elucidates how microglial activation in the hippocampal CA1 region drives neuronal dysregulation and increases seizure susceptibility following acute alcohol exposure. By dissecting the interplay between GABAergic interneuron abundance, glutamatergic signaling, and microglial involvement, the research offers mechanistic insight into alcohol-induced epilepsy and highlights neuroimmune targets for future intervention.

• CFTRinh-172: Precision CFTR Inhibitor for Epithelial Researc

  2026-05-26

  CFTRinh-172 delivers rapid, selective CFTR inhibition, enabling high-resolution dissection of CFTR chloride channel function across epithelial models. This guide provides protocol-ready workflows, troubleshooting strategies, and key insights from recent advances in CFTR trafficking research.

• Tc3 as a Potent Pyroptosis Inducer in Hepatic Carcinoma Ther

  2026-05-26

  This study identifies the indole analogue Tc3 as a selective pyroptosis inducer that suppresses hepatic carcinoma growth through GSDME activation and ROS upregulation. The findings establish a mechanistic bridge between pyroptosis and immune activation, suggesting new synergistic therapeutic strategies for liver cancer.

• Plerixafor (AMD3100): Applied Workflows for CXCR4 Inhibition

  2026-05-25

  Plerixafor (AMD3100) is the benchmark small-molecule CXCR4 antagonist, unlocking precision in cancer metastasis inhibition and hematopoietic stem cell mobilization workflows. This article delivers step-by-step protocol optimizations, advanced use-cases, and troubleshooting strategies—bridging fundamental research and translational impact.

• Pomalidomide (CC-4047): Transforming Hematological Malignanc

  2026-05-25

  Pomalidomide (CC-4047) empowers researchers to dissect tumor microenvironment dynamics and overcome drug resistance in multiple myeloma models. This article provides executable protocols, troubleshooting strategies, and insight-driven applications to maximize the utility of APExBIO’s Pomalidomide in hematological malignancy research.

• Radicicol: A Next-Gen Tool for Precision Adipogenesis and In

  2026-05-24

  Explore how Radicicol, a potent Hsp90 inhibitor, uniquely enables advanced and reproducible modeling of adipocyte differentiation and sepsis inflammation, with mechanistic clarity and practical assay guidance. This article delivers a new perspective on Radicicol’s role in dissecting metabolic and immunological pathways.

• Exemestane: Steroidal Aromatase Inhibitor for Advanced Resea

  2026-05-23

  Exemestane empowers precise, irreversible inhibition of estrogen biosynthesis in breast cancer research and hormone-dependent studies. This guide delivers actionable protocols, troubleshooting strategies, and advanced comparative insights—enabling researchers to maximize experimental reliability and translational relevance.

• RSL3 Drives Distinct PARP1 Apoptotic Mechanisms in Ferroptos

  2026-05-22

  This study uncovers how RSL3, a ferroptosis inducer, triggers two distinct PARP1-dependent apoptotic mechanisms in cancer cells—caspase-mediated cleavage and translational suppression via m6A modification inhibition. These findings highlight a novel crosstalk between ferroptosis and apoptosis, with implications for overcoming PARP inhibitor resistance in tumors.

• Hypoxia-Driven Immunometabolism in Tumor Microenvironment: M

  2026-05-22

  This review dissects how hypoxia and metabolic reprogramming interact to create an immunosuppressive tumor microenvironment (TME), focusing on the underlying mechanisms and therapeutic prospects. The findings highlight the centrality of nutrient competition and redox balance in shaping tumor progression and immune evasion.

• Palomid 529 Enhances Cancer Research via Dual mTORC Inhibiti

  2026-05-21

  Palomid 529 (P529) empowers researchers to dissect and block the PI3K/Akt/mTOR signaling pathway, tackling tumor progression and therapy resistance with precision. Its dual mTORC1/2 inhibition and robust anti-angiogenic profile make it a cornerstone for translational cancer studies and radiotherapy enhancement.

• Prostaglandin E2: Mechanisms and Benchmarks in Inflammation

  2026-05-21

  Prostaglandin E2 (PGE2) is an endogenous lipid mediator central to inflammation research and immune regulation. APExBIO's high-purity PGE2 (SKU B7005) enables reproducible receptor binding and functional studies. This article provides atomic, referenced facts on its mechanism, assay parameters, and clinical benchmarks.

455 records 10/31 page Previous Next First page 上5页 678910 下5页 Last page